FDA warning letters
A warning letter is FDA's formal notice that a company broke the law, usually found during an inspection. The company has 15 working days to reply. Letters that go unanswered lead to seizures, import bans or court orders.
21 letters match. Newest first.
-
DrugsShoplet
FDA warned Shoplet over website sales of unapproved, misbranded triclosan antiseptic lotion soaps.
Medium -
DrugsSave Rite Medical
Save Rite Medical sold triclosan antiseptic lotion soaps online as unapproved, misbranded new drugs.
Medium -
DrugsMedical Mega
FDA: Medical Mega sells unapproved triclosan antiseptic soaps as nonprescription drugs.
Medium -
DrugsNingbo Riway Industrial Co., Ltd.
Ningbo Riway Industrial, an OTC drug maker in China, was cited for manufacturing-practice failures and unapproved antiseptic wipes.
High risk -
DrugsYahon Enterprise Co., Ltd.
FDA warned Yahon Enterprise over manufacturing quality failures for OTC antiseptic wipes after a December 2023 inspection.
High risk -
DrugsBetone S.A. de C.V.
FDA warns Betone S.A. de C.V. over manufacturing violations for OTC antiseptic wipes, including subpotent active and missing glycerin safety tests.
High risk -
DrugsMidlab Incorporated
FDA cited Midlab in Athens, Tennessee for manufacturing violations and unapproved, misbranded hand sanitizer and antibacterial soap drugs.
High risk -
DrugsGascó Industrial Corporation
FDA cites Gascó Industrial for CGMP violations in OTC hand soap, antiseptics, and hand sanitizer, including shared equipment with industrial products.
High risk -
DrugsCofixRx, LLC
FDA warned CofixRx that its CofixRX Nasal Spray is an unapproved, misbranded drug sold with COVID-19 prevention claims.
High risk -
DrugsAgropharma Laboratories, Inc.
FDA cited Agropharma Laboratories in Salinas, Puerto Rico, for serious manufacturing violations affecting its OTC antiseptics and hand sanitizers.
High risk -
DrugsViraldine, LLC
Viraldine sold unapproved povidone-iodine nasal and throat sprays claiming to prevent or treat COVID-19.
High risk -
DrugsProfessional Disposables International, Inc.
Professional Disposables International, a New York drug manufacturer, failed to properly investigate out-of-specification test results for Prevantics antiseptic swabs and Povidone-Iodine products.
High risk -
DrugsSpartan Chemical Company, Inc.
FDA found B. cepacia contamination and CGMP failures at Spartan Chemical’s hand sanitizer plant, plus unapproved COVID-19 claims.
High risk -
DrugsDongBang Cosmetics Co., Ltd.
DongBang Cosmetics of Incheon shipped a hand sanitizer labeled 62% alcohol that tested at 55%, and it was refused at the U.S. border.
High risk -
DrugsBlue Willow Biologics
FDA warned Blue Willow Biologics over its NanoBio Protect nasal antiseptic sold with unapproved COVID-19 prevention and treatment claims.
High risk -
DrugsHalodine, LLC
Halodine, LLC marketed unapproved nasal and oral antiseptic drugs with COVID-19 prevention and treatment claims, FDA says.
High risk -
DrugsBiotek India
Biotek India, an OTC drug maker, lacked active-ingredient testing and sold an unapproved 99% isopropyl rubbing alcohol.
High risk -
DrugsBGP, LLC
FDA and FTC warned BGP, LLC that its Biocence topical antiseptic is an unapproved, misbranded drug sold with COVID-19 treatment and prevention claims.
High risk -
DrugsDisinfect & Shield
FDA warned Disinfect & Shield that its non-alcohol hand sanitizer was an unapproved drug sold with COVID-19 and long-lasting efficacy claims.
High risk -
DrugsHou Fu Biotech - Jiangsu Co., Ltd
Hou Fu Biotech shipped PANROSA hand sanitizer labeled 70% ethanol but tested at 45%, adulterated and misbranded.
High risk -
DrugsGaza Proveedora De Servicios De Hospedaje Y Alimentacion
Gaza Proveedora's Pristine Hand Sanitizer Gel, labeled 68% ethanol, tested at 42% and was refused U.S. admission.
High risk